{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:08:05Z","timestamp":1772172485178,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.brainres.2006.12.078","type":"journal-article","created":{"date-parts":[[2007,1,5]],"date-time":"2007-01-05T08:58:47Z","timestamp":1167987527000},"page":"1-5","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["The peroxisome proliferator-activated receptor gamma (PPAR-\u03b32) Pro12Ala polymorphism is associated with higher risk for Alzheimer's disease in octogenarians"],"prefix":"10.1016","volume":"1139","author":[{"given":"Renato","family":"Scacchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Gambina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Maria","family":"Corbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2006.12.078_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1532-5415.2004.52112.x","article-title":"Diverse effect of inflammatory markers on insulin resistance and insulin-resistance syndrome in the elderly","volume":"52","author":"Abbatecola","year":"2004","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.brainres.2006.12.078_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2006.12.078_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/79216","article-title":"The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes","volume":"26","author":"Altshuler","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.brainres.2006.12.078_bib4","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.brainres.2006.12.078_bib5","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.exger.2004.03.034","article-title":"Gender specific association of genetic variation in peroxisome proliferator-activated receptor (PPAR)gamma-2 with longevity","volume":"39","author":"Barbieri","year":"2004","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.brainres.2006.12.078_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0197-0186(01)00045-6","article-title":"Immunological aspects of microglia: relevance to Alzheimer's disease","volume":"39","author":"Benveniste","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2006.12.078_bib7","article-title":"Statistical methods in cancer research: Vol. I. The analysis of case\u2013control studies","volume":"vol. 32","author":"Breslow","year":"1980"},{"key":"10.1016\/j.brainres.2006.12.078_bib8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00702-003-0018-6","article-title":"Polymorphism in the peroxisome proliferator-activated receptor alpha gene influences the risk for Alzheimer's disease","volume":"110","author":"Brune","year":"2003","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.brainres.2006.12.078_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00062752-200105000-00001","article-title":"Aging and proinflammatory cytokines","volume":"8","author":"Bruunsgaard","year":"2001","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.brainres.2006.12.078_bib10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1203\/01.PDR.0000147728.62185.21","article-title":"PPAR-\u03b32 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity","volume":"57","author":"Buzzetti","year":"2005","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.brainres.2006.12.078_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","article-title":"Insulin and neurodegenerative disease: shared and specific mechanisms","volume":"3","author":"Craft","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2006.12.078_bib12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/3099","article-title":"A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity","volume":"20","author":"Deeb","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.brainres.2006.12.078_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1677\/joe.0.1690453","article-title":"Peroxisome proliferator-activated receptors in inflammation control","volume":"169","author":"Delerive","year":"2001","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.brainres.2006.12.078_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0197-4580(00)00147-0","article-title":"Alzheimer's disease: an inflammatory disease?","volume":"21","author":"Fassbender","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2006.12.078_bib15","first-page":"3989","article-title":"Comment: Studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome","volume":"87","author":"Frederiksen","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainres.2006.12.078_bib16","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.60.12.1886","article-title":"Insulin and Alzheimer's disease: an amyloid connection","volume":"60","author":"Galasko","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2006.12.078_bib17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/1531-8249(20010201)49:2<276::AID-ANA53>3.0.CO;2-5","article-title":"Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease","volume":"49","author":"Heneka","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2006.12.078_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jnr.10501","article-title":"Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation","volume":"71","author":"Kielian","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2006.12.078_bib19","first-page":"E1137","article-title":"Human aging is associated with altered TNF-alpha production during hyperglycemia and hyperinsulinemia","volume":"281","author":"Kirwan","year":"2001","journal-title":"Am. J. Physiol.: Endocrinol. Metab."},{"key":"10.1016\/j.brainres.2006.12.078_bib20","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s001250051225","article-title":"The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects","volume":"42","author":"Koch","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.brainres.2006.12.078_bib21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.exger.2004.01.009","article-title":"Inflammatory mediators in the elderly","volume":"39","author":"Krabbe","year":"2004","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.brainres.2006.12.078_bib22","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0197-4580(01)00296-2","article-title":"Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease","volume":"22","author":"Landreth","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2006.12.078_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.47.2.425","article-title":"Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies","volume":"47","author":"McGeer","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2006.12.078_bib24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS\u2013ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2006.12.078_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.ijo.0801112","article-title":"Impact of the peroxisome proliferator activated receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus","volume":"24","author":"Meirhaeghe","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.brainres.2006.12.078_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2004.08.014","article-title":"Impact of genetic variation of PPARgamma in humans","volume":"83","author":"Meirhaeghe","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.brainres.2006.12.078_bib27","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2337\/diabetes.50.4.891","article-title":"The Pro12\u2192Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes","volume":"50","author":"Mori","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.brainres.2006.12.078_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neurobiolaging.2004.05.010","article-title":"Glia and their cytokines in progression of neurodegeneration","volume":"26","author":"Mrak","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2006.12.078_bib29","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1097\/00004872-200309000-00014","article-title":"Peroxisome proliferator-activated receptor-gammaPro12Ala polymorphism and the association with blood pressure in type 2 diabetes: Skaraborg hypertension and diabetes project","volume":"21","author":"Ostgren","year":"2003","journal-title":"J. Hypertens."},{"key":"10.1016\/j.brainres.2006.12.078_bib30","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/01.ATV.0000068680.19521.34","article-title":"Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction","volume":"23","author":"Ridker","year":"2003","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"10.1016\/j.brainres.2006.12.078_bib32","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00702-004-0267-z","article-title":"Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients","volume":"112","author":"Sauder","year":"2005","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.brainres.2006.12.078_bib31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2006.12.078_bib33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0197-4580(00)00246-3","article-title":"Plasma alpha1-antichymotrypsin in Alzheimer's disease; relationships with APOE genotypes","volume":"22","author":"Scacchi","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2006.12.078_bib34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1515\/CCLM.2002.052","article-title":"Alpha2-macroglobulin deletion polymorphism and plasma levels in late onset Alzheimer's disease","volume":"40","author":"Scacchi","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.brainres.2006.12.078_bib35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1056-8727(01)00203-3","article-title":"Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease","volume":"16","author":"Takano","year":"2002","journal-title":"J. Diabetes its Complicat."},{"key":"10.1016\/j.brainres.2006.12.078_bib36","first-page":"3708","article-title":"Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women","volume":"84","author":"Valve","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainres.2006.12.078_bib37","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1212\/01.WNL.0000065916.25128.25","article-title":"Insulin increases CSF Ab42 levels in normal older adults","volume":"60","author":"Watson","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2006.12.078_bib38","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/0140-6736(91)92823-K","article-title":"Apolipoprotein E genotyping by one-stage PCR","volume":"337","author":"Wenham","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2006.12.078_bib39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/bbrc.1997.7798","article-title":"Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation","volume":"241","author":"Yen","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899307000042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899307000042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T01:56:47Z","timestamp":1547085407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899307000042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":39,"alternative-id":["S0006899307000042"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2006.12.078","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}